Correlates of cervical cancer screening among women living with HIV in Kenya: A cross-sectional study.
HIV
Kenya
cancer screening
cervical cancer
early detection of cancer
health systems
reproductive health
Journal
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
revised:
27
02
2021
received:
30
09
2020
accepted:
27
03
2021
pubmed:
31
3
2021
medline:
15
12
2021
entrez:
30
3
2021
Statut:
ppublish
Résumé
Cervical cancer is the leading cause of cancer-related death among Kenyan women. It is important to identify how demographics and knowledge of cervical cancer are associated with screening to determine best practices for targeted screening efforts. We conducted a sub-analysis of women who were asked about cervical cancer from a cross-sectional study of women attending large HIV care and treatment programs across Kenya between June and September 2016. 1671 of 3007 (56%) women reported ever being screened, 804 (48%) of whom were screened within the last 12 months. Prevalence of screening was highest among women who were older (adjusted prevalence ratio [APR] age 35-49 vs. 18-24: 2.26, 95% CI: 1.68-3.05, P < 0.001), employed (APR: 1.55, 95% CI: 1.24-1.93, P < 0.001), married (APR: 1.27, 95% CI: 1.01-1.59, P = 0.047), had at least secondary education (APR: 1.45, 95% CI: 1.19-1.77, P < 0.001), with longer time since HIV diagnosis (APR: 1.09/year average increase, 95% CI: 1.04-1.13, P < 0.001). 36% knew cervical cancer is treatable. Characteristics linked to social or economic capital are correlated with cervical cancer screening. Integrating cervical cancer screening into HIV care and educating patients on the need for annual screening and potential treatment are important strategies for increasing screening uptake.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
151-158Subventions
Organisme : National Institute for Allergy and Infectious Diseases
Organisme : U.S. President's Emergency Plan for AIDS Relief
ID : U2GPS002047
Organisme : US Centers for Disease Control and Prevention (CDC)
Organisme : Division of Global HIV and TB (DGHT)
Organisme : University of Washington (UW) Global Center for Integrated Health of Women, Adolescents, and Children (Global WACh)
Organisme : UW/Fred Hutch Center for AIDS Research
Organisme : NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NIH HHS
ID : K01 AI116298
Pays : United States
Organisme : NICHD NIH HHS
ID : P2C HD042828
Pays : United States
Organisme : University of Washington
Organisme : NICHD NIH HHS
ID : P2C HD042828
Pays : United States
Informations de copyright
© 2021 International Federation of Gynecology and Obstetrics.
Références
Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Kenya. Summary Report 17 June 2019. https://hpvcentre.net/statistics/reports/KEN.pdf. Accessed September 15, 2020.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
Hawes SE, Critchlow CW, Faye Niang MA, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with Human Immunodeficiency Virus Type 1 and 2 infections. J Infect Dis. 2003;188:555-563.
Ministry of Health, Kenya. National Guidelines for Cancer Management: Kenya. Health Commodities and Services Management. 2013. http://apps.who.int/medicinedocs/en/m/abstract/Js21953en/. Accessed December 2, 2018.
Rositch AF, Gatuguta A, Choi RY, et al. Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS ONE. 2012;7:e40766.
Ghebre RG, Grover S, Xu MJ, Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: past, present and future. Gynecol Oncol. 2017;21:101-108.
Smit JA, Church K, Milford C, Harrison AD, Beksinska ME. Key informant perspectives on policy- and service-level challenges and opportunities for delivering integrated sexual and reproductive health and HIV care in South Africa. BMC Health Serv Res. 2012;12:48.
Colombini M, Mayhew SH, Mutemwa R, Kivunaga J, Ndwiga C. Perceptions and experiences of integrated service delivery among women living with HIV attending reproductive health services in Kenya: a mixed methods study. AIDS Behav. 2016;20:2130-2140.
Sigfrid L, Murphy G, Haldane V, et al. Integrating cervical cancer with HIV healthcare services: a systematic review. PLoS ONE. 2017;12:e0181156.
Suarez L, Roche RA, Nichols D, Simpson DM. Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women. Am J Prev Med. 1997;13:137-142.
Kenya National Bureau of Statistics, Ministry of Health Kenya, National AIDS Control Council Kenya, Kenya Medical Research Institute, National Council for Population and Development Kenya. Kenya Demographic Health Survey 2014. 2015.
Sudenga SL, Rositch AF, Otieno WA, Smith JS. Brief report: knowledge, attitudes, practices and perceived risk of cervical cancer among Kenyan women. Int J Gynecol Cancer. 2013;23:895-899.
Were E, Nyaberi Z, Buziba N. Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya. Afr Health Sci. 2011;11:58-64.
Chen Y, Begnel E, Muthigani W, et al. Higher contraceptive uptake in HIV treatment centers offering integrated family planning services: a national survey in Kenya. Contraception. 2020;102(1):39-45.
PEPFAR. Kenya Country Operational Plan (COP) 2015 Strategic Direction Summary. 2015. https://www.pepfar.gov/documents/organization/250293.pdf. Accessed October 10, 2018.
Breslow N. Generalized linear models: checking assumptions and strengthening conclusions. Stat Appl. 1996;8:19.
Lee J, Chia K. Estimation of prevalence rate ratios for cross sectional data: an example in occupational epidemiology. Br J Ind Med. 1993;50:861-864.
UCLA Institute for Digital Research & Education. Regression with Stata Chapter 2: Regression Diagnostics. https://stats.idre.ucla.edu/stata/webbooks/reg/chapter2/stata-webbooksregressionwith-statachapter-2-regression-diagnostics/. Accessed April 13, 2019.
World Health Organization. WHO World Health Survey: Kenya. 2003. http://apps.who.int/healthinfo/systems/surveydata/index.php/catalog/80. Accessed November 30, 2018.
Shelton RC, Gage-Bouchard EA, Jandorf L, Sriphanlop P, Thelemaque LD, Erwin DO. Examining social capital and its relation to breast and cervical cancer screening among underserved Latinas in the U.S. J Health Care Poor Underserved. 2016;27:1794-1811.
Moudatsou MM, Kritsotakis G, Alegakis AK, Koutis A, Philalithis AE. Social capital and adherence to cervical and breast cancer screening guidelines: a cross-sectional study in rural Crete. Health Soc Care Community. 2014;22:395-404.
World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2013. https://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/. Accessed October 25, 2018.
Ministry of Health, Kenya. Kenya National Cancer Screening Guidelines. 2018. http://www.health.go.ke/wp-content/uploads/2019/02/National-Cancer-Screening-Guidelines-2018.pdf. Accessed February 23, 2019.
Bulterys M, Brotherton J, Chen DS. Prevention of infection related cancers. In: Thun M, Linet MS, Cerhan JR, Haiman CA, Schottenfield D, eds. Cancer epidemiology and prevention. New York, NY: Oxford University Press; 2017.
World Health Organization. World Health Assembly adopts global strategy to accelerate cervical cancer elimination. 2020. https://www.who.int/news-room/detail/19-08-2020-world-health-assembly-adopts-global-strategy-to-accelerate-cervical-cancer-elimination. Accessed September 3, 2020.